D-0392-2016 Class II Terminated

Recalled by Geritrex Corp — Mount Vernon, NY

FDA drug recall D-0392-2016 was initiated by Geritrex Corp on Oct 27, 2015 and is designated Class II. Reason for recall: Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded. The recall status is terminated (terminated Jun 11, 2018). Affected quantity: 844,704 suppositories.

Recall details

Product Type
Drugs
Report Date
Dec 9, 2015
Initiation Date
Oct 27, 2015
Termination Date
Jun 11, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
844,704 suppositories

Product description

GRx HiCort 25 (hydrocortisone acetate 25 mg) Suppositories, 12-count box, Rx only, Distributed by Geritrex Corporation Mount Vernon, NY 10550, NDC 54162-015-12

Reason for recall

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Distribution pattern

Nationwide

Code information

Lot #: 1310001, 13J04, 1310167, 1311013, 1312008, 1401055, 13S02, 14A05, 1402061, 14C01, 14C05, 14C06, 14E02, 1405081, 1406107, 1407062, 14096751, 14096752, 14096753, 15026752, 15026752, 15046752, 15066752, 15066753

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0392-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0392-2016. Report a data issue: hello@regdatalab.com.